masofaniten
Generic: Masofaniten·Code: EPI-7386
masofaniten: 1 clinical trial tracked.
masofaniten evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about masofaniten, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
Phase 2 Trial Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer
Primary endpoint: Biochemical response rate
Interventionalopen13 enrolledStarted 2024-05Completion 2025-012 sites · United StatesPedro Barata, MD, MSc